HighQC™ RFP-Human Bone Marrow-Derived Mesenchymal Stem Cell

RFP-Human Bone Marrow-Derived Mesenchymal Stem Cells (RFP-HBMMSCs) are derived from puromycin-resistant HBMMSCs that have been transfected with RFP-expressing lentiviral particles. They are provided as proliferative cells or cryovials at passage 3-4. Each batch is tested to ensure successful passage for at least three times after thawing. Human mesenchymal stem cells contribute to mesenchymal tissue regeneration and support the growth and differentiation of primitive hemopoietic cells in the bone marrow. However, they do not fulfill all stem cell criteria, lacking the ability to regenerate whole tissue compartments or have indefinite self-renewal. Maintenance requires following a detailed protocol and using complete growth media.

Why choose HighQC™ RFP-Human Bone Marrow-Derived Mesenchymal Stem Cell from AcceGen?

The RFP-HBMMSCs product offers a range of valuable features. It guarantees sterility and is confirmed to be negative for HIV-1, HIV-2, HBV, HCV, bacteria, yeast, and mycoplasma. The cells exhibit high viability, ensuring their functionality. With a focus on standardized production, the product maintains consistency and reliability across batches. Professional operation by experienced experts ensures proper handling and processing. Rigorous quality control measures are implemented, including comprehensive testing and validation, to ensure the cells’ quality, purity, and performance. Overall, the RFP-HBMMSCs product provides researchers with a safe, standardized, and high-quality solution, backed by professional expertise and meticulous quality assurance.